MRI/MRCP与超声内镜在胰胆疾病中的互补作用
本文为修订综述,定义MRI/MRCP与超声内镜在胰胆疾病诊断和治疗决策中的互补角色。重点讨论小实性胰腺病变、胰腺囊性病变、胰胆微结石、自身免疫性胰腺炎模拟病变及治疗性EUS应用。提出选择性影像路径以支持临床决策。
要点
- EUS应作为MRI/MRCP的补充问题解决手段,而非替代。
- 当MRI/MRCP结果模棱两可或与临床不符时,EUS增量价值最大。
- EUS可提供组织取样、囊液分析及选择性治疗干预。
核心结论
- MRI/MRCP仍是胰胆疾病评估的基础技术,提供胰腺实质、胆道及周围结构的全面无创评估。
- EUS是补充性问题解决手段,当横断面成像后仍有特定未解问题且结果可能改变管理时,增量价值最大。
研究设计与样本
- 本文为修订综述,未报告具体检索范围、纳入文献数量及证据分级方法。
关键影像表现/征象
- EUS可显示胰胆微结石及自身免疫性胰腺炎模拟病变。
- MRI/MRCP优化协议可提高对胆道梗阻、胰腺囊性病变及多种炎性或肿瘤性胰腺疾病的诊断性能。
诊断标准与关键数值
- MRI/MRCP对胆道梗阻、胰腺囊性病变及多种炎性或肿瘤性胰腺疾病具有高诊断性能,但原文未报告具体敏感度、特异度、AUC或阈值。
临床应用与阅片要点
- 关注小实性胰腺病变、胰腺囊性病变、胰胆微结石、自身免疫性胰腺炎模拟病变及治疗性EUS应用场景。
- EUS在解剖结构改变、胃出口梗阻、胰尾病变及多灶性神经内分泌肿瘤中存在局限。
- 可采用选择性影像路径以支持临床驱动的决策。
局限性
- EUS在解剖结构改变、胃出口梗阻、胰尾病变及多灶性神经内分泌肿瘤中存在局限。
- 原文未报告该综述的检索范围与纳入文献标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
MRI and magnetic resonance cholangiopancreatography (MRCP) remain foundational techniques for the evaluation of pancreatobiliary disease because they provide a comprehensive, non-invasive assessment of the pancreatic parenchyma, biliary tree and surrounding structures. With optimized protocols, MRI/MRCP has high diagnostic performance for biliary obstruction, pancreatic cystic lesions and many inflammatory or neoplastic pancreatic disorders. Nevertheless, selected clinical scenarios remain challenging when findings are equivocal, discordant with biochemical or clinical suspicion, or insufficient to guide intervention. Endoscopic ultrasound (EUS) should therefore be understood not as a replacement for MRI/MRCP, but as a complementary problem-solving modality. Its incremental value is greatest when a specific unresolved question remains after cross-sectional imaging and when the result is likely to change management. Beyond high-resolution proximity-based imaging, EUS can provide tissue acquisition, cyst fluid analysis, molecular testing, contrast-enhanced assessment, elastography and selected therapeutic interventions. This revised review defines the complementary roles of MRI/MRCP and EUS in pancreatobiliary disease, with emphasis on small solid pancreatic lesions, pancreatic cystic lesions, pancreaticobiliary microlithiasis, autoimmune pancreatitis mimics, and therapeutic EUS applications. We also discuss MRI/MRCP protocol optimization, emerging deep learning-based MRI reconstruction, and the limitations of EUS in altered anatomy, gastric outlet obstruction, pancreatic tail lesions and multifocal neuroendocrine tumors. A practical selective imaging pathway is proposed to support clinically driven decision-making.
引用
- Bolaños Bermúdez, Torres Castiblanco, Munive Gnecco, et al. MRI/MRCP and endoscopic ultrasound in pancreatobiliary disease: defining complementary roles in diagnostic and therapeutic decision-making. Eur J Radiol. 2026. PMID: 42401074. doi:10.1016/j.ejrad.2026.113046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。